作者
M Grazia Cotticelli, Shujuan Xia, Daniel Lin, Taehee Lee, Leila Terrab, Peter Wipf, Donna M Huryn, Robert B Wilson
发表日期
2019/4/1
期刊
Journal of Pharmacology and Experimental Therapeutics
卷号
369
期号
1
页码范围
47-54
出版商
American Society for Pharmacology and Experimental Therapeutics
简介
Friedreich ataxia (FRDA) is a progressive neuro- and cardio-degenerative disorder characterized by ataxia, sensory loss, and hypertrophic cardiomyopathy. In most cases, the disorder is caused by GAA repeat expansions in the first introns of both alleles of the FXN gene, resulting in decreased expression of the encoded protein, frataxin. Frataxin localizes to the mitochondrial matrix and is required for iron-sulfur-cluster biosynthesis. Decreased expression of frataxin is associated with mitochondrial dysfunction, mitochondrial iron accumulation, and increased oxidative stress. Ferropotosis is a recently identified pathway of regulated, iron-dependent cell death, which is biochemically distinct from apoptosis. We evaluated whether there is evidence for ferroptotic pathway activation in cellular models of FRDA. We found that primary patient-derived fibroblasts, murine fibroblasts with FRDA-associated mutations, and …
引用总数
20192020202120222023202472529211722
学术搜索中的文章
MG Cotticelli, S Xia, D Lin, T Lee, L Terrab, P Wipf… - Journal of Pharmacology and Experimental …, 2019